Release Date: 07/01/16 17:02 Summary: Appendix 3B - Option Conversion Price Sensitive: No Download Document 123.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%